Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma Jul 07, 2025
Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference Jun 20, 2025
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV Jun 09, 2025
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights May 15, 2025
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights May 14, 2025
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates May 13, 2025
Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025 May 07, 2025
